Does R&D pay?

Drug Discovery Today
David Cavalla, Raman Minhas

Abstract

Pharmaceutical R&D is notoriously risky, lengthy and costly; moreover, it does not always produce products of blockbuster status. The conventional route of fully discovering, developing and marketing a new chemical entity is followed by the large pharmaceutical companies, whereas other organizations in the pharmaceutical sector--such as generic or specialty companies and biotechnology companies--only operate over portions of the full R&D process. Here, we compare the ten-year financial performance of these three subsectors through their price/earnings ratios and their return on capital metrics to understand which of these strategic alternatives offered the best return to investors.

Citations

Dec 20, 2011·Drug Discovery Today·Youssef L Bennani
Jun 28, 2011·Drug Discovery Today·Youssef L Bennani
Nov 26, 2010·Drug Discovery Today·Craig JohnstoneJonas A Pettersson
Jan 6, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M D StegallR B Mannon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Related Papers

Nature
George M Whitesides, John Deutch
Nature Reviews. Drug Discovery
Bethan Hughes
The Journal of Pharmacology and Experimental Therapeutics
Michael Williams
Nature Reviews. Drug Discovery
Josef Walker
© 2022 Meta ULC. All rights reserved